Indeed, hyperinsulinemia, hyperglycemia, ROS, and inflammatory cytokines can rapidly upregulate and activate SREBP1c and cause severe hepatic steatosis, as seen in obesity, NAFLD, and the early stages of T2DM [56,70,71,72]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.